Medicare Enrolled
Dr. Harish Gagneja, MD
Gastroenterology · Austin, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gagneja from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gagneja?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gagneja
Dr. Harish Gagneja is a gastroenterology specialist in Austin, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gagneja performed 1,245 Medicare services across 1,176 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gagneja received a total of $643,542 from 72 pharmaceutical and/or device companies across 1336 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gagneja is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 16% volume in TX
$643,542 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,245
Medicare services
Top 16% in TX for gastroenterology
1,176
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~62 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
226 | $61 | $160 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
190 | $174 | $1,171 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
189 | $88 | $235 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
175 | $68 | $592 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
131 | $72 | $883 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
77 | $73 | $235 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
47 | $103 | $365 |
| Liver stiffness measurement A non-invasive test that uses ultrasound or similar technology to measure the stiffness of liver tissue. This measurement helps assess the degree of liver fibrosis or scarring. |
34 | $23 | $75 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
33 | $177 | $803 |
| Esophageal dilation with guide wire and endoscope A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage. |
28 | $97 | $694 |
| Removal of large bowel tissue using flexible endoscope A procedure to remove tissue from the large intestine using a flexible tube with a camera. The endoscope allows the provider to access and excise the tissue directly. |
25 | $248 | $818 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
24 | $66 | $575 |
| Endoscopy of digestive tract Imaging of the digestive tract performed from the inside using an endoscope. |
22 | $611 | $2,200 |
| Esophageal polyp or growth removal via endoscope A procedure to remove a polyp or growth from the esophagus using a flexible tube with a camera. The device is inserted through the mouth to access and destroy the abnormal tissue. |
18 | $119 | $486 |
| Injection beneath large bowel lining via endoscope A flexible endoscope is used to inject medication or fluid beneath the lining of the large intestine. |
15 | $12 | $855 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
11 | $179 | $818 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$643,542
Total received (2018-2024)
Avg $91,935/year across 7 years
Top 1% in TX for gastroenterology
72
Companies
1,336
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$390,880 (60.7%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$148,882 (23.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$46,974 (7.3%)
Other
Charitable contributions, space rental, and other categories
$30,935 (4.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,871 (4.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$123,520
2023
$47,185
2022
$76,251
2021
$47,488
2020
$161,905
2019
$76,977
2018
$110,216
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Covidien LP
$155,316
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$107,551
Phathom Pharmaceuticals, Inc.
$100,127
Medtronic, Inc.
$58,420
Synergy Pharmaceuticals Inc
$56,391
GENZYME CORPORATION
$46,101
Regeneron Healthcare Solutions, Inc.
$23,753
Gilead Sciences, Inc.
$21,476
RedHill Biopharma Inc.
$15,412
Ferring Pharmaceuticals Inc.
$7,964
ABBVIE INC.
$7,875
Celgene Corporation
$4,193
E.R. Squibb & Sons, L.L.C.
$4,182
Takeda Pharmaceuticals U.S.A., Inc.
$4,001
Aries Pharmaceuticals, Inc.
$3,391
GastroGPO, LLC
$3,232
Wilson Cook Medical Incorporated
$3,184
Ferring International Pharmascience Center US
$3,000
Micro-tech Endoscopy USA, Inc.
$2,506
Janssen Scientific Affairs, LLC
$1,753
Alfasigma USA, Inc.
$1,529
PFIZER INC.
$1,442
Cook Medical LLC
$1,035
AbbVie, Inc.
$1,034
AbbVie Inc.
$1,033
Ambu Inc.
$911
Janssen Biotech, Inc.
$778
Shire North American Group Inc
$648
Allergan Inc.
$574
Boston Scientific Corporation
$444
BOSTON SCIENTIFIC CORPORATION
$409
Creo Medical Inc.
$298
Olympus America Inc.
$284
UCB, Inc.
$271
Ardelyx, Inc.
$211
Exact Sciences Corporation
$174
C2 Therapeutics, Inc
$157
PENTAX of America, Inc.
$147
Ethicon US, LLC
$143
ERBE USA INC
$135
AnX Robotica Corp
$126
GI Supply, Inc.
$123
Nestle HealthCare Nutrition Inc.
$120
Lilly USA, LLC
$116
Medivators Inc.
$108
Cook Incorporated
$108
NESTLE HEALTHCARE NUTRITION INC.
$105
Amgen Inc.
$102
Ironwood Pharmaceuticals, Inc
$101
CONMED Corporation
$100
Endogastric Solutions, Inc
$94
AIMMUNE THERAPEUTICS, INC.
$89
Johnson & Johnson Health Care Systems Inc.
$87
Iterative Scopes, Inc.
$70
Merck Sharp & Dohme LLC
$62
Madrigal Pharmaceuticals
$61
Axonics Modulation Technologies, Inc.
$56
QOL Medical, LLC
$50
INTERCEPT PHARMACEUTICALS, INC.
$43
Intercept Pharmaceuticals, Inc.
$42
Prometheus Laboratories Inc.
$36
Organon LLC
$33
Celltrion USA Inc.
$32
ERBE USA Inc
$31
Mauna Kea Technologies, Inc.
$29
Shionogi Inc
$23
AMAG Pharmaceuticals, Inc.
$22
IRONWOOD PHARMACEUTICALS, INC
$21
EISAI INC.
$20
Cumberland Pharmaceuticals, Inc.
$17
Organon Llc
$17
CapsoVision, Inc.
$13
Top 3 companies account for 56.4% of total payments
Associated products mentioned in payments ›
AGILE · AMITIZA · APRISO · AVSOLA · Aemcolo · AirWave · All Products · Amitiza · Axonics r-SNM System · BARRX · BILIARY STENT INTRODUCER · Barrx · C2 CRYOBALLOON · CLENPIQ · CONMED Biliary · CONMED HEMOSTASIS · COOK MEDICAL HEMOSPRAY · COOK MEDICAL HEMOSTASIS · CREON · CapsoCam Plus · Cimzia · Cologuard Collection Kit · Computer Software · Cook Medical Biliary · Cook Medical Evolution · Cook Medical Hemospray · Cook Medical Metal Stents · Cytosponge · DEFENDO STERILE SINGLE USE VALVES · DIFICID · DUPIXENT · Dexilant · ELEVIEW · ENDOFLIP · ENTYVIO · ESOPHYX · EXALT BX 2 · EXALT BX 4 · EXALT Model D · Enbrel · EndoClot PHS · EndoFlip · Endocuff Vision · Entyvio · Epclusa · FERAHEME · FUSION · GATTEX · GENERAL THERAPIES · GENERAL BILIARY DEVICES · GENERAL ENDOCHOICE · GENERAL BILIARY DEVICES · GI GENIUS · GI Genius · HADLIMA · HIGH DEFINITION LCD MONITOR · HUMIRA · Humira · IBSRELA · INFLECTRA · INSPIRA · INSTINCT · Instinct · KRISTALOSE · LINX Reflux Management System · LINZESS · Lenvima · Linzess · Lockado · MAVYRET · MOTEGRITY · Mavyret · Movantik · N/A · OCALIVA · OMVOH · ORISE · OverStitch NXT Endoscopic Suturing System · Ozanimod · PILLCAM · PLENVU · REBYOTA · RELISTOR · REMICADE · RENFLEXIS · RESMETIROM · REZDIFFRA · RINVOQ · SKOUT · SKYRIZI · SONARMED AIRWAVE · SPEEDBOAT · STELARA · SUCRAID · Smart Pill · Sucraid · Symproic · TREMFYA · TRULANCE · Talicia · Trulance · VEGZELMA · VELSIPITY · VIBERZI · VIO3 APC3 · VIO300D · VOQUEZNA · VOWST · WATCHMAN · XELJANZ · XIFAXAN · XIFAXANIBSD · XIFIXAN · ZENPEP · ZEPOSIA · ZYMFENTRA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (61%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for gastroenterology in TX.
Equivalent to $51,690 per 100 Medicare services performed
Geographic Context
Gastroenterologists within 10 mi
78
Per 100K population
6.0
County median income
$97,169
Nearest hospital
ASCENSION SETON MEDICAL CENTER AUSTIN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gagneja is a clinical cardiology specialist, with above-average Medicare volume (top 16% in TX), with speaking/promotional industry engagement in the top 1% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gagneja experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Gagneja performed 226 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gagneja receive payments from pharmaceutical companies?
Yes. Dr. Gagneja received a total of $643,542 from 72 companies across 1,336 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gagneja's costs compare to other gastroenterologists in Austin?
Dr. Gagneja's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gagneja) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Austin
Browse gastroenterologists in Austin ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in TX
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in TX
Which TX gastroenterologists receive the most from drug and device companies.
By company
Covidien LP Payments to Doctors
See all physicians who received payments from Covidien LP.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Phathom Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Phathom Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology